SANDOSTATIN LAR Adverse Event: Malignant neoplasm progression
SANDOSTATIN LAR Adverse Event: Malignant neoplasm progression is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: SANDOSTATIN LAR; Product category: Drug; Primary reaction: Malignant neoplasm progression.
| Primary drug | SANDOSTATIN LAR |
|---|---|
| Product category | Drug |
| Primary reaction | Malignant neoplasm progression |
| All reactions | Malignant neoplasm progression; General physical health deterioration |
| Seriousness | Serious |
| Patient outcome | Fatal |
| Patient sex | Male |
| All drugs reported | SANDOSTATIN LAR |
| Reporter country | FR |
| Reporter type | 1 |
| Report date | 20140312 |
| Report ID | 10004121 |
$299/mo
Try FDATracker →